Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy;Évaluation de la densité minérale osseuse chez les patients hyperthyroïdiens, et après contrôle de l'hyperthyroïdie par traitement médical

Annales d'Endocrinologie

Volumn 67, Issue 1, 2006, Pages 27-31

  Safi, S ^a   Hassikou, H ^a   Hadri, L ^a   Sbihi, A ^b   Kadiri, A ^c  

^a Military Hospital Moulay Ismail   (Morocco)

^b Cabinet de Radiologie de l'Agdal   (Morocco)

^c IBN SINA HOSPITAL   (Morocco)

Author keywords

Bone mineral density; Hyperthyroidism; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; EUTHYROIDISM; FEMALE; FEMUR NECK; HUMAN; HYPERTHYROIDISM; LUMBAR SPINE; MALE; MENOPAUSE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; RADIODENSITOMETRY;

ANTITHYROID AGENT; CARBIMAZOLE;

ADULT; AGED; ANTITHYROID AGENTS; BONE DENSITY; CARBIMAZOLE; DENSITOMETRY, X-RAY; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MENOPAUSE; MIDDLE AGED;

EID: 33646005808     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(06)72536-7     Document Type: Article

References (15)

1. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid stimulating hormone. Ann Intern Med 2001 ; 134 : 561-8.
2. Cummings SR, Nevitt MC, Browner WS et al. Risk factors of hip factures in white women. N Engl J Med 1995 ; 332 : 767-73.
3. Diamond T, Vine J, Smart R, Butler P. Thyreotoxic bone disease in women : a potentially reversible disorder. Ann Intern Med 1994 ; 120 : 8-11.
4. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to I-thyroxine treatment: a metaanalysis. European journal of Endocrinology 1994 ; 130 : 350-6.
5. Gomez A, Schott AM, Hans D, Niepomniszcze H, Mautalen CA, Meunier PJ. Hyperthyroidism influences ultrasound bone on the os calcis. Osteoporos int 1998 ; 8 : 455-9.
6. Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada-Charneco M, Lund Del Castillo JD. Bone loss in hyperthyroid patients and in former hyperhroid patients controlled on medical therapy: influence of aetiology and menopause. Clinical Endocrinology 1997 ; 47 : 279-85.
7. Krolner B, Torgensen JV, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 1983 ; 18 : 439-46.
8. Langdahl BL, Loft AGT, Ericksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 1996 ; 6 : 161-8.
9. Lee MS, Kim KY, Lee HK, Koh CS, Min HK. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 1990 ; 70 : 766-70.
10. Lupoli G, Nuzzo V, Di Carlo C et al. Effects of alendronate on bone loss in pre and postmenopausal hyperthyroid women treated with méthimazole. Gynecological Endocrinology 1996 ; 10 : 343-8.
11. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin 1990 ; 19 : 35-6.
12. Muddle AH, Reijnders FJL, Neieuwenhuijzen KAC. Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol (Oxf) 1992 ; 37 : 35-9.
13. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyreotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 1992 ; 75 : 1531-4.
14. Von Recklinghausen FC. Die fibrose oder deformierende ostitis, die osteomalazie und die osteplastische karzinose in ihren gegenseitigen beziehungen. In Festschrift Rudolph Virchow, Berlin, G Reimer 1891 : 1-89.
15. Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density in patients with hyperthyroidism mesasured by dual energy x-ray absorptometry. Clin Endocrinol 1993 ; 38 : 283-6.